sprite-preloader
Anzeige
Mehr »
Mittwoch, 12.12.2018 Börsentäglich über 12.000 News von 600 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 936263 ISIN: GB0003385308 Ticker-Symbol: P8W 
Aktie:
Branche
Finanzdienstleistungen
Aktienmarkt
FTSE-250
1-Jahres-Chart
WORLDWIDE HEALTHCARE TRUST PLC Chart 1 Jahr
1-Woche-Intraday-Chart
WORLDWIDE HEALTHCARE TRUST PLC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
32,20
33,20
28.09.
07.12.2018 | 18:04
(7 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

Worldwide Healthcare Trust Plc - Issue of Equity

PR Newswire

WORLDWIDE HEALTHCARE TRUST PLC

7 December 2018

Allotment of Ordinary Shares

WORLDWIDE HEALTHCARE TRUST PLC (the "Company") announces the allotment of 50,000 Ordinary shares of 25p each fully paid from its block listing authority dated 18 December 2017.

These Ordinary shares were issued today at a price of 2605.00 pence per share, which equates to a premium to the estimated cum income net asset value at the time of transaction of 0.8%. The ex-dividend cum income net asset value per Ordinary share at the close of business on 6 December 2018 was 2617.89 pence per share.

Following this issue, the Company has the ability to issue a further 22,477 shares under this block listing authority.

Following this transaction the Company hereby notifies the market that it has in issue 51,765,278 Ordinary shares of 25p each all with voting rights. No shares were held in treasury at the date of announcement.

The figure of 51,765,278 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 008 4913


© 2018 PR Newswire